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Introduction
Stroke is a major cause of serious, long-term disability and the third leading cause of
death, accounting for one in every 18 deaths in the United States. Approximately 800,000
strokes occur in the United States each year, leading to an estimated cost of 74 billion
dollars in 2010. The severity and prognosis of patients with an acute internal carotid
artery (ICA) occlusion is extremely poor. Studies have shown that 16-55% of patients will die from
complications related to the infarction, 40-69% will be left with a profound deficit, and only 2-12%
will make a reasonable recovery2. In young patients, internal carotid artery dissections presenting
as an acute occlusion or thrombotic clot are responsible for approximately 14-20% of ischemic
strokes.1 Results from trials utilizing emergent open surgical carotid recanalization or IVtPA have
not been encouraging2,3. Recently, there have been small case reports of endovascular stent-assisted
thrombolysis as a treatment option for patients with carotid occlusions and near occlusions.4-8

Treatment Paradigm
At Jefferson Hospital for Neuroscience, we have developed an aggressive treatment protocol for
patients with acute internal carotid occlusions. On admission, all patients are assessed by the NIH
Stroke Scale (NIHSS). Prior to endovascular intervention, a non-contrast head CT is performed
as a pre-operative baseline. In addition, CT angiography and CT perfusion studies are obtained
emergently. The decision to proceed with endovascular thrombolysis is based on clinical and radiographic analysis of pre-operative data. In summary, a minimum NIHSS of 6, CT perfusion with
ischemic penumbra on mean transient time and cerebral blood flow but preservation of cerebral
blood volume, and a detectable arterial occlusion on CT angiography are inclusion criteria for
patient intervention.
All procedures are performed under general endotracheal anesthesia. Digital subtraction angiography is obtained focusing on the affected carotid circulation. An 8 French femoral sheath and 8 French
guide catheter are used in most cases. An SL-10 and Transcend wire is used to cross the carotid bifurcation and determine the extent of the carotid occlusion. At that time, the decision is made for balloon
angioplasty and carotid stenting. Balloon angioplasty is performed with an AVIATORTM or ViatracTM
balloon across the occluded segment and a Precise® or ACCULINKTM stent is then deployed across the
occluded internal carotid segment to the ipsilateral common carotid artery. Once the carotid artery
is opened, angiography is performed to assess the intracerebral circulation. If a cutoff is still seen in
the middle cerebral artery, further thrombolytic methods are utilized such as balloon angioplasty
(HyperglideTM balloon), Merci® or Penumbra® systems for aspiration and mechanical thrombolysis.
If mechanical thrombolysis is unsuccessful, and ictus is within 8 hours, pharmacologic thrombolysis
is performed with intra-arterial tPA or ReoPro®. Finally, in all patients final angiography is performed
to assess patency of the carotid circulation.

Discussion

The prognosis of acute ischemic stroke in the setting of a carotid occlusion or near occlusion has
been shown to be extremely poor. The use of IV tPA has been the standard of care to date for
patients with ischemic stroke presenting within a 4.5 hour time window from symptom onset. In
the general setting of acute ischemic stroke, complete recanalization is achieved in only 30-40% of

patients and less than 50% of patients on long
term follow-up. In our study of acute carotid
occlusions, these outcomes may be even less
encouraging. Studies comparing the recanalization rates with IV TPA for acute ischemic
stroke due to carotid occlusions compared to
smaller vessel occlusions have shown very poor
results9–12. Rubiera et al reported that patients
with tandem occlusions were 3 times less
likely to achieve recanalization as measured
on follow-up by transcranial dopplers.3 In this
setting, emergent carotid endarterectomy has
been attempted as a method to recanalize the
ICA, however results were similarly discouraging.2
The presence of a carotid occlusion may reflect
an alteration of hemodynamic conditions and
poor exposure to the thrombolytic agent deterring an effective response to systemic thrombolysis.13 Hemodynamically, carotid occlusions or
near occlusions may contribute to blood stasis
increasing the risk of distal restenosis or thrombosis after incomplete recanalization. Studies
have shown that re-occlusion was four times
more likely in patients with a proximal carotid
and tandem distal occlusion when compared to
the general acute ischemic stroke population.3
While it is controversial and not the standard
of care, the use of endovascular interventions
to recanalize ICA occlusions has recently
been reported in several case reports.4,6–8,14
Historically, the risk of traversing the occluded
ICA had been thought to outweigh the benefits
of thrombectomy due to dislodging more distal
emboli and the risk of perforation or dissection. Lavallee et al reported their experience
with endovascular stent-assisted thrombolysis
in six patients.7 Three-month clinical followup showed neurological improvement when
compared to a similar population receiving
IV tPA only. Baumgartner et al reported their
experience in four patients treated by carotid
stenting and intra-arterial thrombolysis for ICA
dissections causing tandem occlusions.8 They
observed similar outcomes when compared to
14 similar patients treated with IV tPA alone.
Mourand et al reported on two patients with
internal carotid dissections causing tandem
MCA occlusion treated by self-expandable/
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Figure 1
Cerebral angiograms showing proximal internal carotid artery occlusion thrombolysis and stenting, followed by tandem middle cerebral artery occlusion thrombolysis.
(A,B) digital subtraction angiogram in the working projection showing the fronral and lateral views of the occluded internal carotid artery. (C) Frontal DSA showing
recanalization of the previously occluded vessel, following balloon. (D,E) Tandem middle cerebral artery (M1) occlusion. (F,G) DSA frontal and lateral projections
showing successful recanalization of the MCA after balloon angioplasty and Penumbra retrieval. (H–I) DSA fronal and lateral projections showing final arterial runs of
the internal carotid artery displaying sustained patency of the carotid circulation.
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stents and IA tPA with excellent outcomes at
1 year follow-up.6 Overall, these studies suggested this technique to be technically feasible
with recanalization rates from 37–100% and
clinical improvement of 53–94%.5
In our institution, the goal of endovascular
intervention is to restore blood flow to ischemic
areas and decrease the extent of cerebral blood
volume loss. Urgent recanalization of the ICA
allows full access to tandem MCA thrombus for
either chemical or mechanical thrombolysis.
After recanalization, carotid stent placement
also protects the vessel in the presence of an
intimal tear, reducing the risk of re-occlusion
and further embolic events. In our institution,
revascularization of the carotid and intracranial
circulations is achieved in approximately 89% of
patients. Our clinical outcome shows improvement of all patient’s NIHSS from an average
of 15 on admission to 7 on discharge. While
all patients are initially densely hemiplegic, an
average of 50% are ambulatory on discharge.

Conclusion

In conclusion, an aggressive endovascular
stroke protocol combining urgent carotid
artery stenting with intracranial thrombolysis
for acute internal carotid and tandem middle
cerebral artery occlusions in the setting of
ischemic stroke offers a feasible and efficacious
intervention that compares favorably to the use
of ivTPA.
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